tradmap

CAI Caris Life Sciences, Inc.

$25.32 +2.14%

Updated

Healthcare · Services-Medical Laboratories

Caris Life Sciences, Inc. (CAI) is a healthcare company in the Services-Medical Laboratories industry, with a market capitalization of $7.2 billion. Shares last traded at $25.32, 31.2% below their 52-week high. Over the past year the stock is down 31.2%. CAI trades at a price-to-earnings ratio of 68.06, above the Services-Medical Laboratories median of 26.82. Net profit margin is 10.6%, above the peer median of -5.4%. Revenue grew 97.0% year over year.

Market Cap
$7.2B
Shares Out
282.6M
EPS (TTM)
$-17.63
P/E Ratio
68.06
P/S Ratio
7.23
P/B Ratio
12.09
Dividend / Share
Dividend Yield
52-Week High
$36.81
52-Week Low
$14.19
Volume
432,414
Avg Vol (3m)
293,081.603

Performance

1W
-4.09%
1M
+33.97%
3M
+46.57%
6M
+31.74%
YTD
-6.14%
1Y
-31.23%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
62.41
SMA (50)
$19.90
SMA (200)
$20.95
Price vs SMA50
+27.26%
Price vs SMA200
+20.84%
ATR (14)
$1.65

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$990M
Net Income
$105M
Gross Margin
Operating Margin
15.5%
Net Margin
10.6%
Return on Equity
17.8%
Return on Assets
8.6%
Current Ratio
5.53
Debt / Equity
0.66
Revenue Growth (YoY)
+97.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.00 2026-08-05
Q1 2026 $0.00 2026-05-08
FY 2025 $-3.22 2026-03-03
Q3 2025 $-4.83 2025-11-05
Q2 2026 $-12.80 2026-08-05
Q1 2026 $-3.57 2026-05-08

Full earnings history →

Services-Medical Laboratories peers

CAI vs 14 industry peers (Services-Medical Laboratories), by market cap. Updated

P/E vs peers
68.06 / 26.82 med
+154% premium
P/S vs peers
7.23 / 2.75 med
+163% premium
Net margin vs peers
10.6% / -5.4% med
above median
1–14 of 14
NTRANatera, Inc.$47.2B-245.2617.43-7.1%+0.66%
LHLabcorp$26.9B26.821.877.0%-0.07%
DGXQuest Diagnostics$26.4B24.882.299.2%-0.58%
GHGuardant Health, Inc.$21.6B-47.6518.26-38.3%-1.23%
CAICaris Life Sciences, Inc.$7.2B68.067.2310.6%+2.14%
RDNTRadnet, Inc.$5.9B-278.182.59-0.9%-1.36%
CELCCelcuity Inc.$4.7B-20.82+0.06%
BLLNBilliontoone, Inc.$4.6B121.8611.569.5%+3.64%
GRALGrail, Inc.$3.6B-9.19+0.03%
VCYTVeracyte, Inc.$3.6B31.356.3920.4%-0.65%
CDNACaredx, Inc.$2.6B23.225.6324.2%+0.44%
PSNLPersonalis, Inc.$1.8B-16.77+0.51%
FTREFortrea Holdings Inc.$1.8B-20.770.66-3.2%+1.47%
LMRILumexa Imaging Holdings, Inc.$1.1B-1.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.